Simulations Plus (SLP)

Common Shares
Sell: $18.15|Buy: $19.50|Change: 0.19 (1.02%)

Open 

$18.63


Previous close 

$18.56


Trade high 

$18.97


Volume 

489,655


Year high 

$37.665


Year low 

$12.39


Dividend yield 


Market capitalisation 

$377.71 mn


P/E ratio 

48.53


ISIN 

US8292141053


Share price

Dividends

PreviousLatest
Record date29/04/202429/07/2024
Ex-dividend date26/04/202429/07/2024
Payment date06/05/202405/08/2024
Amount$0.06$0.06

Performance 19/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Simulations Plus+ 1.02
More...

Company profile

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.